Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DHAI DIH Holding US	$0.25 +1.4%	$0.25	$0.12 ▼ $2.93	$11.98M	0.07	1.83 million shs	72,056 shs
MLSS Milestone Scientific	$0.59 -2.2%	$0.70	$0.38 ▼ $1.39	$46.07M	0.8	218,856 shs	56,464 shs
PSTV Plus Therapeutics	$0.70	$0.40	$0.16 ▼ $2.31	$42.28M	0.67	19.88 million shs	4.92 million shs
WOK WORK Medical Technology Group	$0.77 -2.7%	$0.78	$0.36 ▼ $8.45	$43.53M	N/A	1.40 million shs	3,852 shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DHAI DIH Holding US	-7.21%	+1.46%	-3.26%	+31.44%	-88.86%
MLSS Milestone Scientific	-4.61%	+10.91%	-8.46%	-32.97%	-36.46%
PSTV Plus Therapeutics	-11.95%	-5.29%	+94.61%	+0.29%	-51.72%
WOK WORK Medical Technology Group	-0.05%	+3.50%	+6.28%	+42.45%	+79,499,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DHAI DIH Holding US	1.0285 of 5 stars	0.0	5.0	0.0	0.0	1.9	1.7	0.0
MLSS Milestone Scientific	2.0397 of 5 stars	3.5	3.0	0.0	0.0	0.6	2.5	0.0
PSTV Plus Therapeutics	1.9055 of 5 stars	3.3	4.0	0.0	0.0	1.1	0.0	0.6
WOK WORK Medical Technology Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DHAI DIH Holding US	0.00	N/A	N/A	N/A
MLSS Milestone Scientific	3.00	Buy	$1.25	114.04% Upside
PSTV Plus Therapeutics	2.50	Moderate Buy	$10.83	1,430.13% Upside
WOK WORK Medical Technology Group	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest DHAI, PSTV, WOK, and MLSS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/27/2025	PSTV Plus Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$5.50 ➝ $3.00
6/25/2025	PSTV Plus Therapeutics	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$9.00
6/5/2025	PSTV Plus Therapeutics	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$20.00 ➝ $20.50

(Data available from 8/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DHAI DIH Holding US	$64.47M	0.19	N/A	N/A	($0.80) per share	-0.32
MLSS Milestone Scientific	$8.61M	5.32	N/A	N/A	$0.11 per share	5.31
PSTV Plus Therapeutics	$5.82M	7.36	N/A	N/A	($1.52) per share	-0.47
WOK WORK Medical Technology Group	$11.51M	3.83	N/A	N/A	$1.10 per share	0.71

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DHAI DIH Holding US	-$8.44M	-$0.30	N/A	∞	N/A	-13.59%	N/A	-25.97%	N/A
MLSS Milestone Scientific	-$6.93M	-$0.07	N/A	∞	N/A	-52.01%	-60.26%	-40.23%	N/A
PSTV Plus Therapeutics	-$12.98M	-$2.94	N/A	N/A	N/A	-520.90%	N/A	-202.73%	8/13/2025 (Estimated)
WOK WORK Medical Technology Group	-$3.49M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest DHAI, PSTV, WOK, and MLSS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/13/2025	Q2 2025	PSTV Plus Therapeutics	-$0.12	N/A	N/A	N/A	$1.08 million	N/A
5/30/2025	Q1 2025	PSTV Plus Therapeutics	-$0.17	-$0.56	-$0.39	-$1.19	$1.11 million	$1.06 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DHAI DIH Holding US	N/A	N/A	N/A	N/A	N/A
MLSS Milestone Scientific	N/A	N/A	N/A	N/A	N/A
PSTV Plus Therapeutics	N/A	N/A	N/A	N/A	N/A
WOK WORK Medical Technology Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DHAI DIH Holding US	N/A	0.51	0.34
MLSS Milestone Scientific	N/A	2.85	1.86
PSTV Plus Therapeutics	N/A	1.03	1.03
WOK WORK Medical Technology Group	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DHAI DIH Holding US	27.76%
MLSS Milestone Scientific	5.79%
PSTV Plus Therapeutics	3.28%
WOK WORK Medical Technology Group	N/A

Insider Ownership

Company	Insider Ownership
DHAI DIH Holding US	49.58%
MLSS Milestone Scientific	24.75%
PSTV Plus Therapeutics	0.79%
WOK WORK Medical Technology Group	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DHAI DIH Holding US	N/A	47.34 million	23.87 million	N/A
MLSS Milestone Scientific	30	78.48 million	58.61 million	Optionable
PSTV Plus Therapeutics	20	60.49 million	60.01 million	Not Optionable
WOK WORK Medical Technology Group	226	56.53 million	N/A	N/A

DHAI, PSTV, WOK, and MLSS Headlines

Recent News About These Companies

Univest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)

May 22, 2025 | globenewswire.com

WORK Medical Technology Group LTD Announces Closing of Registered Offering

May 22, 2025 | globenewswire.com

WORK Medical Technology Group LTD Announces Pricing of Registered Offering

May 21, 2025 | globenewswire.com

WORK Medical Technology Group LTD Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

April 11, 2025 | globenewswire.com

WORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025

March 5, 2025 | globenewswire.com

WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.

February 28, 2025 | globenewswire.com

WORK Medical Technology Group LTD Reports Financial Results for Fiscal Year 2024

February 14, 2025 | prnewswire.com

WORK Medical Technology Group LTD's Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024

November 27, 2024 | globenewswire.com

WORK Medical Technology Group LTD Announces Partial Exercise of Underwriters' Over-Allotment Option

August 29, 2024 | globenewswire.com

WORK Medical Technology Group LTD Announces Closing of Initial Public Offering

August 26, 2024 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

DHAI, PSTV, WOK, and MLSS Company Descriptions

DIH Holding US NASDAQ:DHAI

$0.25 +0.00 (+1.36%)

As of 11:37 AM Eastern

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.

Milestone Scientific NYSE:MLSS

$0.59 -0.01 (-2.20%)

As of 11:38 AM Eastern

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Plus Therapeutics NASDAQ:PSTV

$0.70 0.00 (0.00%)

As of 11:43 AM Eastern

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

WORK Medical Technology Group NASDAQ:WOK

$0.77 -0.02 (-2.67%)

As of 11:43 AM Eastern

WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time